Complex Regional Pain Syndrome Treated with Intravenous Immunoglobulin in a Patient with Common Variable Immune Deficiency
- Raffi Tachdjian
- … show all 1 hide
Common variable immunodeficiency (CVID) represents a large heterogeneous group of antibody-deficiency syndromes associated with a wide range of clinical features and a lack of defined causes in the realm of primary immunodeficiencies. Here, we present a case of CVID in a 62-year-old white male patient with a history of longstanding complex regional pain syndrome (CRPS).
His medical history included multiple sinus infections per year and several pneumonias requiring antibiotics. He has had various back surgeries, including a laminectomy at the L4 level 1 year prior to his diagnosis. Thereafter, he underwent four sympathetic nerve blocks with minimal pain relief. Blood chemistries showed a normal white blood cell count with a normal differential, but increased erythrocyte sedimentation rate and C-reactive protein levels. Total Ig (Immunoglobulin)G was 611 mg/dL (normal 700–1,600), IgG1 was 425 mg/dL (341–894), IgG2 was 114 mg/dL (171–632), IgG3 was 14.4 mg/dL (18.4–106), and IgG4 was 7.4 mg/dL (2.4–121). IgA was 47 mg/dL (normal 70–400), IgM was 131 mg/dL (40–230), and IgE was 4.5 kU/L (<4.0). He only had 10 of 23 pneumococcal titers in the protective range post-vaccination. Upon treatment of the CVID with intravenous immunoglobulin, the patient’s pain levels were significantly decreased and have been maintained for more than 2 years.
Therefore, immunoglobulin therapy appears to have been beneficial in the treatment of the patient’s symptoms of CRPS, including pain. Additional studies investigating the mechanism by which immunoglobulin therapy may reduce the inflammation and pain of CRPS are needed.
- International Association for the Study of Pain. Classification of chronic pain: 2nd edn (Revised) Part II, Section A. Relatively generalized syndromes, complex regional pain syndromes, 2012. p. 4–7.
- Marinus J, et al. Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol. 2011;10(7):637–48. CrossRef
- Harden RN, et al. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;8(4):326–31. CrossRef
- de Mos M, Huygen FJ, Dieleman JP, et al. Medical history and the onset of complex regional pain syndrome (CRPS). Pain. 2008;139(2):458–66. CrossRef
- Cunningham-Rundles C. Common variable immunodeficiency. Curr Allergy Asthma Rep. 2001;1(5):421–9. CrossRef
- Spickett GP, et al. Common variable immunodeficiency: how many diseases? Immunol Today. 1997;18(7):325–8. CrossRef
- Bonilla FA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94(5 Suppl 1):S1–63. CrossRef
- Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Curr Allergy Asthma Rep. 2009;9(5):347–52. CrossRef
- Lin LH, et al. Common variable immunodeficiency mimicking rheumatoid arthritis with Sjogren’s syndrome. J Microbiol Immunol Infect. 2005;38(5):358–60.
- Swierkot J, et al. Rheumatoid arthritis in a patient with common variable immunodeficiency: difficulty in diagnosis and therapy. Clin Rheumatol. 2006;25(1):92–4. CrossRef
- Goebel A, et al. Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial. Ann Intern Med. 2010;152(3):152–8. CrossRef
- Patwa HS, Chaudhry V, Katzberg H, Rae-Grant AD, So YT. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2012;78(13):1009–15. CrossRef
- Amato AA, Cornman EW, Kissel JT. Treatment of stiff-man syndrome with intravenous immunoglobulin. Neurology. 1994;44(9):1652–4. CrossRef
- Karlson EW, et al. Treatment of stiff-man syndrome with intravenous immune globulin. Arthritis Rheum. 1994;37(6):915–8. CrossRef
- Gonzalez H, et al. Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial. Lancet Neurol. 2006;5(6):493–500. CrossRef
- Werhagen L, Borg K. Effect of intravenous immunoglobulin on pain in patients with post-polio syndrome. J Rehabil Med. 2011;43(11):1038–40. CrossRef
- Gonzalez H, et al. Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up. J Neuroinflamm. 2012;9:167. CrossRef
- Jann S, et al. Efficacy and safety of intravenous immunoglobulin as adjuvant treatment for refractory neuropathic pain. Results of an open-label, multicenter study. Pain Med. 2012;13(10):1334–41. CrossRef
- Clinicaltrials.gov: Intravenous gammaglobulin for sickle cell pain crises. 2013. http://clinicaltrials.gov/show/NCT00644865. Last Accessed 10 Sept 2013.
- Samson M, et al. Diagnostic strategy for patients with hypogammaglobulinemia in rheumatology. Joint Bone Spine. 2011;78(3):241–5. CrossRef
- Complex Regional Pain Syndrome Treated with Intravenous Immunoglobulin in a Patient with Common Variable Immune Deficiency
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Pain and Therapy
Volume 2, Issue 2 , pp 129-134
- Cover Date
- Print ISSN
- Online ISSN
- Springer Healthcare
- Additional Links
- Common variable immune deficiency
- Complex regional pain syndrome
- Intravenous immunoglobulin
- Industry Sectors
- Raffi Tachdjian (1)
- Author Affiliations
- 1. Division of Clinical Immunology and Allergy, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA